🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.810
+0.130 (7.74%)
At close: Nov 20, 2026, 4:00 PM EST
1.870
+0.060 (3.31%)
After-hours: Nov 20, 2026, 7:59 PM EST

Pyxis Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.8615.4219.479.66179.29274.74
Short-Term Investments
51.7251.44107.46109.63--
Cash & Short-Term Investments
55.5766.86126.93119.3179.29274.74
Cash Growth
-27.12%-47.33%6.40%-33.46%-34.74%3300.19%
Other Receivables
-0.7--0.6-
Receivables
-0.7--0.6-
Prepaid Expenses
2.080.590.761.011.311.76
Restricted Cash
1.471.471.471.471.471.47
Other Current Assets
-2.493.282.823.940.7
Total Current Assets
59.1372.11132.44124.6186.61278.67
Property, Plant & Equipment
17.6419.4222.1424.8124.771.24
Other Intangible Assets
--2.624.31--
Other Long-Term Assets
-----0.11
Total Assets
76.7791.52157.18173.73211.38280.02

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8.1210.894.863.97.111.95
Accrued Expenses
9.938.1210.7312.6223.456.33
Current Portion of Leases
1.891.691.451.23-0.17
Current Unearned Revenue
---7.66--
Other Current Liabilities
-0.430.640.361.090.27
Total Current Liabilities
19.9421.1317.6825.7631.6318.71
Long-Term Leases
15.5116.9818.7520.118.92-
Long-Term Deferred Tax Liabilities
---2.16--
Total Liabilities
35.4538.1136.4348.0250.5618.71

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.060.060.050.030.03
Additional Paid-In Capital
553.07496.47484.08411.82373.23353
Retained Earnings
-511.78-443.18-363.56-286.23-212.44-91.72
Comprehensive Income & Other
-0.060.050.170.06--
Total Common Equity
41.3253.41120.75125.7160.82261.31
Shareholders' Equity
41.3253.41120.75125.7160.82261.31
Total Liabilities & Equity
76.7791.52157.18173.73211.38280.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
17.418.6720.221.3318.920.17
Net Cash (Debt)
38.1748.18106.7397.97160.37274.57
Net Cash Growth
-33.25%-54.85%8.95%-38.91%-41.59%3661.23%
Net Cash Per Share
0.560.781.832.464.8532.33
Filing Date Shares Outstanding
119.6162.8361.5958.1336.8332.22
Total Common Shares Outstanding
83.5162.6959.9744.7534.9632.17
Working Capital
39.1950.97114.7698.85154.98259.97
Book Value Per Share
0.490.852.012.814.608.12
Tangible Book Value
41.3253.41118.15101.4160.82261.31
Tangible Book Value Per Share
0.490.851.972.274.608.12
Machinery
-4.154.194.523.281.9
Construction In Progress
----9.18-
Leasehold Improvements
-10.7410.7410.960.530.23
SEC Filings: 10-K · 10-Q